Mirzaten Q-Tab (Mirtazapine)

Mirtazapine, the active ingredient in Mirzaten Q-Tab, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as an oral tablet for oral use. It belongs to the class of noradrenergic and specific serotonergic antidepressants and is used to treat major depressive disorder in adult patients, improving mood and sleep quality.

GNH USA supplies Mirzaten Q-Tab as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to EU quality standards, and serves hospitals, pharmacies and clinics worldwide with reliable sourcing and regulatory support.

Mirtazapine is a noradrenergic and specific serotonergic antidepressant used primarily in the management of depressive disorders.

- Major depressive disorder: alleviates depressive symptoms, improves mood and sleep. - Depression with insomnia: promotes sleep onset and reduces nighttime awakenings. - Depression with anxiety: helps reduce anxiety symptoms associated with depressive episodes.

Mirtazapine may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Sedation: feeling of drowsiness or sleepiness. - Increased appetite and weight gain: heightened hunger leading to weight increase. - Dry mouth: reduced salivation causing oral dryness. - Constipation: slowed intestinal transit resulting in hard stools.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells requiring immediate medical attention. - Suicidal thoughts: emergence of suicidal ideation, especially early in treatment. - Severe allergic reactions: rash, swelling, or difficulty breathing indicating hypersensitivity.

When prescribing Mirtazapine, clinicians should consider several safety precautions.

- Pregnancy: consult a healthcare provider as safety data are limited. - Elderly patients: monitor for excessive sedation and increased fall risk. - History of bipolar disorder: may trigger mood switching to mania. - Liver impairment: dose adjustment may be necessary due to altered metabolism. - Concomitant CNS depressants: may enhance sedative effects. - Store at ambient temperature: keep in original container, protect from moisture and light.

Mirtazapine can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis or serotonin syndrome. - Other serotonergic agents: may increase serotonin syndrome risk.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine): can raise mirtazapine plasma levels. - CYP inducers (e.g., carbamazepine): may reduce effectiveness. - CNS depressants (e.g., alcohol, benzodiazepines): enhance sedation.